SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001206774-21-002245
Filing Date
2021-08-19
Accepted
2021-08-19 06:01:49
Documents
9

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE ADDITIONAL PROXY SOLICITING MATERIALS uthr3924131-defa14a.htm DEFA14A 41481
2 GRAPHIC uthr3924131-defa14alogo.jpg GRAPHIC 24189
3 GRAPHIC uthr3924131-defa14ax1x1.jpg GRAPHIC 12311
4 GRAPHIC uthr3924131-defa14ax1x2.jpg GRAPHIC 34142
5 GRAPHIC uthr3924131-defa14ax1x3.jpg GRAPHIC 5260
6 GRAPHIC uthr3924131-defa14ax1x4.jpg GRAPHIC 3207
7 GRAPHIC uthr3924131-defa14ax1x5.jpg GRAPHIC 4754
8 GRAPHIC uthr3924131-defa14ax1x6.jpg GRAPHIC 5564
9 GRAPHIC uthr3924131-defa14ax2x1.jpg GRAPHIC 1106
  Complete submission text file 0001206774-21-002245.txt   168545
Mailing Address 1040 SPRING ST SILVER SPRING MD 20910
Business Address 1040 SPRING ST SILVER SPRING MD 20910 3016089292
UNITED THERAPEUTICS Corp (Filer) CIK: 0001082554 (see all company filings)

IRS No.: 521984749 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-26301 | Film No.: 211188319
SIC: 2834 Pharmaceutical Preparations